📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease. (2014)

First Author: Smith MR

Attributed to: Targeting the innate immune system in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddu010

PubMed Identifier: 24436303

Publication URI: http://europepmc.org/abstract/MED/24436303

Type: Journal Article/Review

Volume: 23

Parent Publication: Human molecular genetics

Issue: 11

ISSN: 0964-6906